Skip to content

A Clinical Assessment of Glass Carbomer Cement

A Clinical Assessment of Class II Glass Carbomer Cement Restorations Compared to Resin Modified Glass Ionomer Cement and Composite Resin Restorations in Primary Molars.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03030690
Enrollment
50
Registered
2017-01-25
Start date
2016-11-30
Completion date
2018-01-31
Last updated
2018-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries Class II

Keywords

Proximal Dental Caries, Glass Carbomer, Hydroxyapatite Enhanced Glass Ionomer, Primary Teeth

Brief summary

This study will evaluate the clinical performance of glass carbomer cement restorations in restoring proximal lesions in primary molars compared to that of resin modified glass ionomer cement and composite resin restorations. Teeth will be randomly assigned to one of the three restoration groups and the restorations will be evaluated clinically and radiographically every six months.

Detailed description

Glass Carbomer is a monomer free; carbomised nano-glass restorative cement developed from traditional glass ionomer cement (GIC) and contains nano-sized powder particles of hydroxyapatite and fluorapatite. These materials claim to have improved mechanical properties and better bonding to dentin, in addition to continues fluoride release. The study is a randomized controlled clinical trial where teeth will be randomly assigned to one of the three restoration groups. Following medical and dental history, bilateral bitewing radiographs will be taken for each patient to assess the presence of proximal lesions. Suitable teeth will then be randomly assigned to one of the restoration groups. A single operator using local anesthesia and rubber dam isolation will then prepare standardized Class II cavities and place the designated restorations according to the manufacturer's instructions. The quality of the 3 types of restorations will be clinically evaluated at baseline and every six months for color match, marginal discoloration, anatomic form, marginal adaptation, and secondary caries using the criteria described by Cvar and Ryge (2005). The evaluation will be performed by 2 calibrated examiners. Following placement of the restorations, bitewing radiographs will be taken to evaluate the restorations and will be repeated every six months for detection of recurrent caries.

Interventions

OTHERGlass Carbomer Cement

Restoration of proximal lesions in primary molars using glass carbomer cement

Restoration of proximal lesions in primary molars using composite resin.

Restoration of proximal lesions in primary molars using resin modified glass ionomer cement

Sponsors

King Abdulaziz University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* One proximal lesion in a primary molar. * Radiographic evidence of caries extending at least into the inner half of the enamel but not the inner half of dentin. * Proximal contact with adjacent healthy or restored teeth. * Occlusal contact with opposing healthy or restored teeth. * No indication for pulp therapy or other restorative treatment. * A predicted survival until exfoliation of 2 years.

Exclusion criteria

* Radiographic evidence of caries extending into the inner half of dentin. * No proximal contact with adjacent healthy or restored teeth. * No occlusal contact with opposing healthy or restored teeth. * Tooth indicated for pulp therapy or other restorative treatment. * A predicted survival until exfoliation of less than 2 years.

Design outcomes

Primary

MeasureTime frameDescription
clinical success rate of glass carbomer cement in restoring proximal lesions in primary molars.2 Yearsthe clinical success of glass carbomer cement in restoring proximal lesions compared to the success of resin modified glass ionomer cement and composite resin.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026